Limits...
Comparative proteomic analysis of serum from patients with systemic sclerosis and sclerodermatous GVHD. Evidence of defective function of factor H.

Scambi C, La Verde V, De Franceschi L, Barausse G, Poli F, Benedetti F, Sorio M, Deriu F, Roncada P, Bortolami O, Turrini F, Caramaschi P, Stranieri C, Bambara LM, Biasi D - PLoS ONE (2010)

Bottom Line: In addition, we observed that FH binding to ECs was reduced when we used serum from these patients.The comparative proteomic analysis of serum from SSc and ScGVHD patients highlighted proteins involved in either promoting or maintaining an inflammatory state.We also found a defective function of Factor H, possibly associated with ECs damage.

View Article: PubMed Central - PubMed

Affiliation: Section of Rheumatology, Department of Clinical and Experimental Medicine, University of Verona, Verona, Italy. cinzia.scambi@univr.it

ABSTRACT

Background: Systemic sclerosis (SSc) is an autoimmune disease characterized by immunological and vascular abnormalities. Until now, the cause of SSc remains unclear. Sclerodermatous graft-versus-host disease (ScGVHD) is one of the most severe complications following bone marrow transplantation (BMT) for haematological disorders. Since the first cases, the similarity of ScGVHD to SSc has been reported. However, both diseases could have different etiopathogeneses. The objective of this study was to identify new serum biomarkers involved in SSc and ScGVHD.

Methodology: Serum was obtained from patients with SSc and ScGVHD, patients without ScGVHD who received BMT for haematological disorders and healthy controls. Bi-dimensional electrophoresis (2D) was carried out to generate maps of serum proteins from patients and controls. The 2D maps underwent image analysis and differently expressed proteins were identified. Immuno-blot analysis and ELISA assay were used to validate the proteomic data. Hemolytic assay with sheep erythrocytes was performed to evaluate the capacity of Factor H (FH) to control complement activation on the cellular surface. FH binding to endothelial cells (ECs) was also analysed in order to assess possible dysfunctions of this protein.

Principal findings: Fourteen differentially expressed proteins were identified. We detected pneumococcal antibody cross-reacting with double stranded DNA in serum of all bone marrow transplanted patients with ScGVHD. We documented higher levels of FH in serum of SSc and ScGVHD patients compared healthy controls and increased sheep erythrocytes lysis after incubation with serum of diffuse SSc patients. In addition, we observed that FH binding to ECs was reduced when we used serum from these patients.

Conclusions: The comparative proteomic analysis of serum from SSc and ScGVHD patients highlighted proteins involved in either promoting or maintaining an inflammatory state. We also found a defective function of Factor H, possibly associated with ECs damage.

Show MeSH

Related in: MedlinePlus

Synthetic referring gels of haematological patients.A comparative proteomic analysis of serum from patients with ScGVHD or without ScGVHD and before BMT was conducted to identify differently expressed protein spots. Only protein spots that were present in almost 75% of the total samples of each subject category were included in the synthetic referring gels.
© Copyright Policy
Related In: Results  -  Collection


getmorefigures.php?uid=PMC2921355&req=5

pone-0012162-g004: Synthetic referring gels of haematological patients.A comparative proteomic analysis of serum from patients with ScGVHD or without ScGVHD and before BMT was conducted to identify differently expressed protein spots. Only protein spots that were present in almost 75% of the total samples of each subject category were included in the synthetic referring gels.

Mentions: The comparative proteomic analysis was conducted on serum of some SSc and ScGVHD patients (lSSc n = 10; dSSc n = 10; ScGVHD n = 8). In addition, we evaluated 2D serum maps of T patients without GVHD (n = 5) and ScGVHD patients before BMT (n = 8). To simplify the image master 2D software analysis, we created synthetic referring gels of each haematological patient subgroups, as previously described (Fig. 4). The serum protein profile of ScGVHD patients resulted quite similar to that of SSc patients (Fig. 1, Table 3), but was different from those of ScGVHD patients before BMT and T patients without GVHD (Fig. 4).


Comparative proteomic analysis of serum from patients with systemic sclerosis and sclerodermatous GVHD. Evidence of defective function of factor H.

Scambi C, La Verde V, De Franceschi L, Barausse G, Poli F, Benedetti F, Sorio M, Deriu F, Roncada P, Bortolami O, Turrini F, Caramaschi P, Stranieri C, Bambara LM, Biasi D - PLoS ONE (2010)

Synthetic referring gels of haematological patients.A comparative proteomic analysis of serum from patients with ScGVHD or without ScGVHD and before BMT was conducted to identify differently expressed protein spots. Only protein spots that were present in almost 75% of the total samples of each subject category were included in the synthetic referring gels.
© Copyright Policy
Related In: Results  -  Collection

Show All Figures
getmorefigures.php?uid=PMC2921355&req=5

pone-0012162-g004: Synthetic referring gels of haematological patients.A comparative proteomic analysis of serum from patients with ScGVHD or without ScGVHD and before BMT was conducted to identify differently expressed protein spots. Only protein spots that were present in almost 75% of the total samples of each subject category were included in the synthetic referring gels.
Mentions: The comparative proteomic analysis was conducted on serum of some SSc and ScGVHD patients (lSSc n = 10; dSSc n = 10; ScGVHD n = 8). In addition, we evaluated 2D serum maps of T patients without GVHD (n = 5) and ScGVHD patients before BMT (n = 8). To simplify the image master 2D software analysis, we created synthetic referring gels of each haematological patient subgroups, as previously described (Fig. 4). The serum protein profile of ScGVHD patients resulted quite similar to that of SSc patients (Fig. 1, Table 3), but was different from those of ScGVHD patients before BMT and T patients without GVHD (Fig. 4).

Bottom Line: In addition, we observed that FH binding to ECs was reduced when we used serum from these patients.The comparative proteomic analysis of serum from SSc and ScGVHD patients highlighted proteins involved in either promoting or maintaining an inflammatory state.We also found a defective function of Factor H, possibly associated with ECs damage.

View Article: PubMed Central - PubMed

Affiliation: Section of Rheumatology, Department of Clinical and Experimental Medicine, University of Verona, Verona, Italy. cinzia.scambi@univr.it

ABSTRACT

Background: Systemic sclerosis (SSc) is an autoimmune disease characterized by immunological and vascular abnormalities. Until now, the cause of SSc remains unclear. Sclerodermatous graft-versus-host disease (ScGVHD) is one of the most severe complications following bone marrow transplantation (BMT) for haematological disorders. Since the first cases, the similarity of ScGVHD to SSc has been reported. However, both diseases could have different etiopathogeneses. The objective of this study was to identify new serum biomarkers involved in SSc and ScGVHD.

Methodology: Serum was obtained from patients with SSc and ScGVHD, patients without ScGVHD who received BMT for haematological disorders and healthy controls. Bi-dimensional electrophoresis (2D) was carried out to generate maps of serum proteins from patients and controls. The 2D maps underwent image analysis and differently expressed proteins were identified. Immuno-blot analysis and ELISA assay were used to validate the proteomic data. Hemolytic assay with sheep erythrocytes was performed to evaluate the capacity of Factor H (FH) to control complement activation on the cellular surface. FH binding to endothelial cells (ECs) was also analysed in order to assess possible dysfunctions of this protein.

Principal findings: Fourteen differentially expressed proteins were identified. We detected pneumococcal antibody cross-reacting with double stranded DNA in serum of all bone marrow transplanted patients with ScGVHD. We documented higher levels of FH in serum of SSc and ScGVHD patients compared healthy controls and increased sheep erythrocytes lysis after incubation with serum of diffuse SSc patients. In addition, we observed that FH binding to ECs was reduced when we used serum from these patients.

Conclusions: The comparative proteomic analysis of serum from SSc and ScGVHD patients highlighted proteins involved in either promoting or maintaining an inflammatory state. We also found a defective function of Factor H, possibly associated with ECs damage.

Show MeSH
Related in: MedlinePlus